High Potency API Contract Manufacturing Market Is Expected To Reach USD 14.65 Billion By 2030
San Francisco, 10 Aug 2023: The Report High Potency API Contract Manufacturing Market Size, Share & Trends Analysis Report By Product Type (Innovative, Generic), By Dosage Form (Injectable, Creams), By Application, By Synthesis, And Segment Forecasts, 2022 - 2030 The global high potency API contract manufacturing market size is expected to reach USD 14.65 billion by 2030, registering a CAGR of 9.0% over the forecast period, according to a new report by Grand View Research, Inc. The main drivers of this market are rising demand for oncology drugs, advancements in manufacturing technology, and a rise in capacity to meet the increasing demand. Also, a rise in target therapies to cure chronic diseases is going to accelerate industry growth. The COVID-19 pandemic boosted the demand for high potency APIs (HPAPIs). During the first half of the pandemic, the supply chain was disrupted, which reduced research-based activities. However, during the second half, the industry started to ga